Lonza
Lonza is a Switzerland-based biotechnology company that develops and commercializes small molecule, specialty ingredients and related products for the pharmaceutical industry.
Business Model:
Revenue: $6.7B
Employees: 10,001-999,999
Rankings
Industries / Tags:
Detailed Lonza Information
Lonza was acquired by
Bain Capital Private Equity.
The acquisition happend on 2021-02-09.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Muenchensteinerstrasse 38
City: Basel
State: basel-city
Zip: 4002
Country: CH
Financial Info
Stage:
Raised Last:
$0
Raised Total:$874M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Lonza is a Switzerland-based biotechnology company that develops and commercializes small molecule, specialty ingredients and related products for the pharmaceutical industry.
Contact Phone:
Contact Email:
Lonza went public on the SIX Swiss Exchange
Listed Exchange:
SIX Swiss Exchange
Ticker Symbol:
LONN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2013 | Odyssey Thera | Venture Round | 0 |
| 12/2016 | ConnectedYard (pHin) | Series A | 0 |
| 5/2021 | Affinia Therapeutics | Series B | 0 |
| 3/2020 | Affinia Therapeutics | Series A | 0 |
| 5/2017 | Exosomics Siena | Funding Round | - |
| 10/2009 | Cilian AG | Corporate Round | - |
| 2/2022 | Indapta Therapeutics | Series A | 0 |
| 2/2022 | Indapta Therapeutics | Series A | 0 |
| 5/2021 | Affinia Therapeutics | Series B | 0 |
| 3/2020 | Affinia Therapeutics | Series A | 0 |
| 5/2017 | Exosomics Siena | Funding Round | - |
| 12/2016 | ConnectedYard (pHin) | Series A | 0 |
| 2/2013 | Odyssey Thera | Venture Round | 0 |
| 10/2009 | Cilian AG | Corporate Round | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2017 | Equity | $874M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 6/2023 | Synaffix BV | |
| 11/2021 | Codiak Biosciences | |
| 10/2018 | Octane Biotech | |
| 8/2017 | Micromacinazione | |
| 5/2017 | PharmaCell | |
| 5/2017 | HansaBioMed | |
| 12/2016 | Capsugel | |
| 8/2016 | InterHealth Nutraceuticals | |
| 6/2016 | Triangle Research Labs | |
| 11/2015 | Diacon Technologies Ltd. |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
